European Medicines Agency (EMA) | What's new Follow Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously Vyxeos), daunorubicin,cytarabine, Date of authorisation: 23/08/2018, Revision: 11, Status: Authorised https://www.ema.europa.eu/en/medicines/human/EPAR/vyxeos-liposomal ema.europa.eu
